Portal de Periódicos da CAPES

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

2015; Elsevier BV; Volume: 387; Issue: 10022 Linguagem: Inglês

10.1016/s0140-6736(15)01224-6

1474-547X

Ian Jacobs, Usha Menon, Andy Ryan, Aleksandra Gentry‐Maharaj, Matthew Burnell, Jatinderpal Kalsi, Nazar N. Amso, Sophia Apostolidou, Elizabeth Benjamin, Derek Cruickshank, Danielle N Crump, Susan K Davies, Anne Dawnay, Stephen Dobbs, G. Fletcher, Jeremy Ford, Keith Godfrey, Richard Gunu, Mariam Habib, Rachel Hallett, Jonathan Herod, Howard J. Jenkins, Chloe Karpinskyj, Simon Leeson, Sara Lewis, William R Liston, Alberto Lopes, Tim Mould, John Murdoch, David Oram, Dustin J. Rabideau, Karina Reynolds, Ian Scott, Mourad W. Seif, Aarti Sharma, Naveena Singh, Julie Taylor, Fiona Warburton, Martin Widschwendter, Karin Williamson, Robert Woolas, Lesley Fallowfield, Alistair McGuire, Stuart Campbell, Mahesh Parmar, Steven J. Skates,

Endometrial and Cervical Cancer Treatments

Ovarian cancer has a poor prognosis, with just 40% of patients surviving 5 years. We designed this trial to establish the effect of early detection by screening on ovarian cancer mortality.